GECO Stock Overview
GENETICO PJSC provides genetic diagnostics for hereditary diseases and reproductive disorders. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
GENETICO PJSC Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₽17.88 |
52 Week High | ₽0 |
52 Week Low | ₽0 |
Beta | 0 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
GECO | RU Healthcare | RU Market | |
---|---|---|---|
7D | n/a | -0.2% | -0.4% |
1Y | n/a | 7.2% | 5.3% |
Return vs Industry: Insufficient data to determine how GECO performed against the Russian Healthcare industry.
Return vs Market: Insufficient data to determine how GECO performed against the Russian Market.
Price Volatility
GECO volatility | |
---|---|
GECO Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.4% |
10% most volatile stocks in RU Market | 9.4% |
10% least volatile stocks in RU Market | 2.3% |
Stable Share Price: GECO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GECO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | n/a | genetico.ru |
GENETICO PJSC provides genetic diagnostics for hereditary diseases and reproductive disorders. The company offers whole-genome and whole-exome sequencing, as well as preimplantation genetic testing for chromosomal abnormalities; and non-invasive prenatal testing services. It also provides consultation services.
GENETICO PJSC Fundamentals Summary
GECO fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | -₽116.29m |
Revenue (TTM) | ₽407.29m |
0.0x
P/S Ratio0.0x
P/E RatioIs GECO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
GECO income statement (TTM) | |
---|---|
Revenue | ₽407.29m |
Cost of Revenue | ₽352.67m |
Gross Profit | ₽54.63m |
Other Expenses | ₽170.92m |
Earnings | -₽116.29m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did GECO perform over the long term?
See historical performance and comparison